Do You Qualify for a Depo-Provera Lawsuit? (2026 Guide)

Published November 23, 2025

Updated June 25, 2026

Diagnosed with meningioma after years of Depo-Provera injections? Here is who may qualify, the proof that strengthens a claim, and how to start a free case review.

By Tanya Vorobiova

Chief Marketing Officer

June 2026 status: Pfizer and MDL leadership have reached an agreement in principle to resolve Depo-Provera meningioma claims — a framework, not a final settlement. No public claim form or claim administrator exists yet, so confirming your eligibility now is how you prepare. For the full status, see our Depo-Provera settlement update.

Who May Qualify Meningioma After Depo-Provera Brain or spinal cord tumor diagnosed after medroxyprogesterone acetate injections

Use History Prolonged Use Cases center on repeated injections, often over a period of years

Proof Required Yes Imaging & pathology reports, neurosurgery records, Depo-Provera injection history

Cost to You $0 Review Free case review · attorneys typically work on contingency

Filing Window Limited Statutes of limitations vary by state — deadlines often run from diagnosis

Do You Qualify for a Depo-Provera Lawsuit?

If you received Depo-Provera birth control injections and were later diagnosed with a brain tumor such as meningioma, you may be eligible to bring an individual injury lawsuit. This page walks through the eligibility criteria attorneys use, the diagnoses that typically qualify, the proof that strengthens a claim, and the steps to start a free case review.

Eligibility for a Depo-Provera lawsuit generally comes down to three questions:

• Did you receive Depo-Provera or generic medroxyprogesterone acetate injections? The cases involve the injectable contraceptive, not pills.
• Were you later diagnosed with meningioma or a related brain or spinal cord tumor? The diagnosis is the core of the claim.
• Did the Depo-Provera use come before the tumor diagnosis? The timeline matters, and prolonged use is a common thread in current cases.

If those three line up, a free case review can confirm whether your specific history fits the criteria attorneys are currently using to screen Depo-Provera meningioma claims. With a June 2026 agreement in principle now in place, confirming eligibility and organizing your records is how you prepare for any eventual settlement program.

Which Diagnoses Qualify

The Depo-Provera litigation centers on meningioma — a tumor that grows from the meninges, the membranes surrounding the brain and spinal cord. Diagnoses attorneys typically review for eligibility include:

• Intracranial meningioma
• Multiple meningiomas
• Spinal cord meningioma
• Tumors affecting the meninges around the brain and spinal cord
• Related brain or spinal cord tumors identified by your medical team

Although many meningiomas are considered benign, they can still be serious — requiring surgery, radiation, or long-term monitoring — and the impact on a person's life is part of what an individual claim accounts for.

How Much Depo-Provera Use Is Enough?

There is no single magic number of injections. The lawsuits, and the research behind them, focus on prolonged use of medroxyprogesterone acetate, and many people in these cases received Depo-Provera every three months over a span of years. When evaluating eligibility, an attorney weighs how long and how often you received the injections alongside your diagnosis and timeline. If you used Depo-Provera for an extended period and were later diagnosed with meningioma, it is worth having your history reviewed even if you are unsure exactly how many injections you received.

The Meningioma Symptoms That Often Lead to Diagnosis

Many people in these cases did not connect their tumor to Depo-Provera until after diagnosis. Meningiomas are frequently discovered when symptoms prompt brain imaging. Depending on the tumor's size and location, those symptoms can include:

• Persistent or worsening headaches
• Vision changes or hearing changes
• Seizures
• Balance, memory, or concentration problems
• Weakness or numbness, or changes in personality

If imaging for symptoms like these led to a meningioma diagnosis after years of Depo-Provera use, that is exactly the pattern attorneys are screening for.

What Proof Strengthens Your Eligibility

You do not need a complete file to start a review, but strong documentation makes it easier for attorneys to confirm eligibility and evaluate a claim — and with a settlement framework now being negotiated, having your records ready matters more than ever. The most useful records include:

• MRI and CT imaging reports showing tumor location and size
• Neurosurgery and hospital records for brain or spinal cord tumor treatment
• Pathology reports confirming meningioma or a related tumor
• Gynecology records and clinic notes confirming Depo-Provera injections, dates, and dosing
• Pharmacy records or clinic billing records showing Depo-Provera use
• Personal notes about when symptoms began and how they progressed

If a firm takes your case, it can help obtain records you do not already have, including injection history from clinics and pharmacies.

How to File: The Case Review Steps

• Complete a short intake form: answer basic questions about your Depo-Provera use, diagnosis, and any surgeries to see if you may qualify.
• Speak with an intake team or attorney: they review your information and, if your facts fit, match you with a lawyer who handles Depo-Provera injury cases.
• Gather supporting evidence: if a firm takes your case, it helps collect imaging, pathology, neurosurgery, and injection records.
• Your lawsuit may be filed: depending on your situation, your individual case may be filed and become part of the federal multidistrict litigation.
• Resolution: with an agreement in principle now in place, eligible MDL cases may ultimately resolve through a settlement program once its terms are finalized; outcomes vary widely and nothing is guaranteed.

Completing a case review does not mean you have filed a lawsuit, joined a settlement, retained a lawyer, or preserved any legal deadline. No statute of limitations is stopped until you sign a representation agreement and a firm acts on your behalf.

Deadlines That Can Affect Your Eligibility

Eligibility can be lost to time. There is no single nationwide deadline for Depo-Provera brain tumor lawsuits — each state has its own statute of limitations and, in some cases, statute of repose, which may limit how long you have to file after a diagnosis, after major treatment, or after learning that Depo-Provera might be linked to your condition. The June 2026 agreement in principle does not change these individual deadlines. Because these windows can be short and they vary widely, the safest step is to have your timeline reviewed promptly. A lawyer can explain which deadlines apply to you and whether any exceptions or tolling rules might extend them.

Where the Litigation Stands

The Depo-Provera cases are not a class action with a single claim form. They are individual lawsuits consolidated for pretrial proceedings as MDL No. 3140 in the U.S. District Court for the Northern District of Florida, before Judge M. Casey Rodgers, with more than 5,500 actions pending. In June 2026, Pfizer and the MDL plaintiff leadership announced an agreement in principle to resolve claims, and the court vacated the first bellwether trial deadlines and rescheduled the general-causation hearing — but the settlement terms, payout formulas, and claim process are still being negotiated, no claim administrator has been appointed, and there is no public claim form yet. For the full breakdown of the settlement status and court schedule, see our Depo-Provera settlement update (MDL 3140), and for how consolidated litigation works see our explainer on multidistrict litigation (MDL).

Health and Safety Note

This page provides legal information, not medical advice. For health questions about Depo-Provera, meningioma, or other tumor risks, speak directly with your doctor, neurologist, or neurosurgeon. If you are currently using hormonal contraception, work with your healthcare provider before making any changes to your medication or birth control plan.

Depo-Provera Lawsuit Eligibility FAQ

Do I qualify for a Depo-Provera lawsuit?

You may qualify if you received Depo-Provera or generic medroxyprogesterone acetate birth control injections and were later diagnosed with meningioma or another brain or spinal cord tumor. Attorneys generally look at how long you used the injections, the tumor type and location, your treatment history, and whether Depo-Provera use began before the diagnosis. A free case review is the way to confirm whether your facts fit current screening criteria.

Does the June 2026 agreement in principle mean I can file a claim now?

Not yet. In June 2026 Pfizer and MDL plaintiff leadership announced an agreement in principle to resolve Depo-Provera claims in MDL 3140, but it is a framework, not a final settlement. The eligibility criteria, payout formulas, and claim process are still being negotiated, and no claim administrator has been appointed, so there is no public claim form. The step available now is a free attorney case review to establish your individual eligibility and get your records ready.

What diagnoses qualify for a Depo-Provera brain tumor lawsuit?

Current cases focus on meningioma, including intracranial meningioma, multiple meningiomas, and spinal cord meningioma, as well as related tumors of the meninges around the brain and spinal cord. The qualifying diagnosis usually needs to be supported by imaging and a pathology or neurosurgery record.

How long do I need to have used Depo-Provera to qualify?

There is no single fixed number, but the lawsuits center on prolonged use, and many people in these cases received Depo-Provera injections over a period of years. The research that prompted the litigation focused on long-term use of medroxyprogesterone acetate. An attorney reviewing your case will weigh how long and how often you received the injections along with your diagnosis.

What proof do I need to file a Depo-Provera claim?

Helpful records include MRI or CT imaging reports, neurosurgery and hospital records, pathology reports confirming the tumor type, and gynecology, clinic, or pharmacy records confirming Depo-Provera injections and dates. You do not need every document to start a review; if a firm takes your case, it can help obtain the records.

Does it cost anything to have my Depo-Provera case reviewed?

Case reviews for these cases are typically free, and attorneys who handle Depo-Provera injury claims usually work on a contingency fee basis, meaning a fee is generally owed only if money is recovered. You should always read any fee agreement carefully and ask questions before signing.

Sources

• U.S. District Court, Northern District of Florida — MDL 3140 litigation page
• N.D. Fla. — MDL 3140 orders by date
• JPML — Pending MDL dockets by district, June 1, 2026 (PDF)
• The BMJ — Use of progestogens and intracranial meningioma risk (2024 study)
• National Cancer Institute — meningioma treatment information
• U.S. Food and Drug Administration — drug safety information

See also our related pages: Depo-Provera Settlement Update (MDL 3140) · Mass Tort Lawsuits · What Is an MDL?

Important Disclaimer

Important: Legal deadlines can be time sensitive and vary by state, diagnosis date, exposure history, and other facts. Submitting information through this website does not file a lawsuit, preserve your rights, create an attorney-client relationship, or guarantee that any attorney will contact or represent you. If you do not receive a response, or if you are unsure about a filing deadline, you should promptly contact a qualified attorney of your choice to discuss your specific situation.

About this page: OpenClassActions.com is an informational publishing platform and a marketing / referral platform. We are not a law firm, settlement administrator, claims administrator, or government agency, and we do not provide legal advice. No attorney-client relationship is created by using this site or submitting any form. Submitting a form does not guarantee representation, compensation, eligibility, or participation in any lawsuit or settlement. See our Terms of Service, Privacy Policy, and Advertising Disclosure.

For more class actions keep scrolling below.

Case Title In re: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation

Case Number MDL No. 3140 · Master Docket 3:25-md-03140

Court U.S. District Court, Northern District of Florida

Presiding Judge Hon. M. Casey Rodgers, U.S.D.J.

Status Agreement in Principle (June 2026) Terms being negotiated · no claim administrator appointed

Pending Actions 5,500+ MDL 3140 · more than 5,500 cases as of June 2026

Defendant Pfizer Inc. (and generic medroxyprogesterone acetate manufacturers)

Official Website N.D. Fla. Court MDL 3140 Page

Who Qualifies for a Depo-Provera Brain Tumor Lawsuit? Eligibility, Proof & How to File